APO Research
Talk to an analyst

APO RESEARCH · REPORT

Rifapentine

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Rifapentine Market Outlook and Growth Opportunities 2026

22 December 2025198 pages

Choose your research edition.

Industry ResearchRifapentine Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Rifapentine Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Rifapentine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Rifapentine Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Rifapentine Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Rifapentine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Rifapentine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Rifapentine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Rifapentine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Rifapentine market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Rifapentine market include Changzheng Pharma, Sine Pharma, Sanofi, MED-SHINE and Foutune Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Rifapentine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Rifapentine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Rifapentine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Rifapentine market size, projected growth trends, production technologies, key applications, and end-use industries.

Rifapentine Segment by Company

Changzheng Pharma

Sine Pharma

Sanofi

MED-SHINE

Foutune Pharma

Rifapentine Segment by Type

20 Capsules/Box

24 Capsules/Box

Rifapentine Segment by Application

Retail Pharmacies

Online Pharmacies

Hospital Pharmacies

Rifapentine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Rifapentine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Rifapentine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Rifapentine significant trends, drivers, influence factors in global and regions.

6. To analyze Rifapentine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rifapentine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Rifapentine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rifapentine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Rifapentine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Rifapentine industry.

Chapter 3: Detailed analysis of Rifapentine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Rifapentine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Rifapentine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Rifapentine Industry Trends Table 2. Rifapentine Industry Drivers Table 3. Rifapentine Industry Opportunities and Challenges Table 4. Rifapentine Industry Restraints Table 5. Global Rifapentine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Rifapentine Revenue Share by Company (2021-2026) Table 7. Global Rifapentine Sales Volume by Company (kg) & (2021-2026) Table 8. Global Rifapentine Sales Volume Share by Company (2021-2026) Table 9. Global Rifapentine Average Price (US$/kg) of Company (2021-2026) Table 10. Global Rifapentine Company Ranking, (2024-2026) & (USD Million) Table 11. Global Rifapentine Key Company Manufacturing Base & Headquarters Table 12. Global Rifapentine Company, Product Type & Application Table 13. Global Rifapentine Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Rifapentine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 20 Capsules/Box Table 18. Significant Companies of 24 Capsules/Box Table 19. Global Rifapentine Sales Volume by Type 2021 VS 2025 VS 2032 (kg) Table 20. Global Rifapentine Sales Volume by Type (2021-2026) & (kg) Table 21. Global Rifapentine Sales Volume by Type (2027-2032) & (kg) Table 22. Global Rifapentine Sales Volume Share by Type (2021-2026) Table 23. Global Rifapentine Sales Volume Share by Type (2027-2032) Table 24. Global Rifapentine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Rifapentine Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Rifapentine Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Rifapentine Sales Value Share by Type (2021-2026) Table 28. Global Rifapentine Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Retail Pharmacies Table 30. Significant Companies of Online Pharmacies Table 31. Significant Companies of Hospital Pharmacies Table 32. Global Rifapentine Sales Volume by Application 2021 VS 2025 VS 2032 (kg) Table 33. Global Rifapentine Sales Volume by Application (2021-2026) & (kg) Table 34. Global Rifapentine Sales Volume by Application (2027-2032) & (kg) Table 35. Global Rifapentine Sales Volume Share by Application (2021-2026) Table 36. Global Rifapentine Sales Volume Share by Application (2027-2032) Table 37. Global Rifapentine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Rifapentine Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Rifapentine Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Rifapentine Sales Value Share by Application (2021-2026) Table 41. Global Rifapentine Sales Value Share by Application (2027-2032) Table 42. Global Rifapentine Sales by Region: 2021 VS 2025 VS 2032 (kg) Table 43. Global Rifapentine Sales by Region (2021-2026) & (kg) Table 44. Global Rifapentine Sales Market Share by Region (2021-2026) Table 45. Global Rifapentine Sales by Region (2027-2032) & (kg) Table 46. Global Rifapentine Sales Market Share by Region (2027-2032) Table 47. Global Rifapentine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Rifapentine Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Rifapentine Sales Value Share by Region (2021-2026) Table 50. Global Rifapentine Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Rifapentine Sales Value Share by Region (2027-2032) Table 52. Global Rifapentine Market Average Price (US$/kg) by Region (2021-2026) Table 53. Global Rifapentine Market Average Price (US$/kg) by Region (2027-2032) Table 54. Global Rifapentine Sales by Country: 2021 VS 2025 VS 2032 (kg) Table 55. Global Rifapentine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Rifapentine Sales by Country (2021-2026) & (kg) Table 57. Global Rifapentine Sales Market Share by Country (2021-2026) Table 58. Global Rifapentine Sales by Country (2027-2032) & (kg) Table 59. Global Rifapentine Sales Market Share by Country (2027-2032) Table 60. Global Rifapentine Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Rifapentine Sales Value Market Share by Country (2021-2026) Table 62. Global Rifapentine Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Rifapentine Sales Value Market Share by Country (2027-2032) Table 64. Changzheng Pharma Company Information Table 65. Changzheng Pharma Business Overview Table 66. Changzheng Pharma Rifapentine Sales (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 67. Changzheng Pharma Rifapentine Product Portfolio Table 68. Changzheng Pharma Recent Development Table 69. Sine Pharma Company Information Table 70. Sine Pharma Business Overview Table 71. Sine Pharma Rifapentine Sales (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 72. Sine Pharma Rifapentine Product Portfolio Table 73. Sine Pharma Recent Development Table 74. Sanofi Company Information Table 75. Sanofi Business Overview Table 76. Sanofi Rifapentine Sales (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 77. Sanofi Rifapentine Product Portfolio Table 78. Sanofi Recent Development Table 79. MED-SHINE Company Information Table 80. MED-SHINE Business Overview Table 81. MED-SHINE Rifapentine Sales (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 82. MED-SHINE Rifapentine Product Portfolio Table 83. MED-SHINE Recent Development Table 84. Foutune Pharma Company Information Table 85. Foutune Pharma Business Overview Table 86. Foutune Pharma Rifapentine Sales (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 87. Foutune Pharma Rifapentine Product Portfolio Table 88. Foutune Pharma Recent Development Table 89. Key Raw Materials Table 90. Raw Materials Key Suppliers Table 91. Rifapentine Distributors List Table 92. Rifapentine Customers List Table 93. Research Programs/Design for This Report Table 94. Authors List of This Report Table 95. Secondary Sources Table 96. Primary Sources List of Figures Figure 1. Rifapentine Product Image Figure 2. Global Rifapentine Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Rifapentine Sales Value (2021-2032) & (US$ Million) Figure 4. Global Rifapentine Sales (2021-2032) & (kg) Figure 5. Global Rifapentine Sales Average Price (US$/kg) & (2021-2032) Figure 6. Global Rifapentine Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 20 Capsules/Box Image Figure 10. 24 Capsules/Box Image Figure 11. Global Rifapentine Sales Volume by Type (2021 VS 2025 VS 2032) & (kg) Figure 12. Global Rifapentine Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Rifapentine Sales Volume Share by Type (2021-2032) Figure 14. Global Rifapentine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Rifapentine Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Rifapentine Sales Value Share by Type (2021-2032) Figure 17. Retail Pharmacies Image Figure 18. Online Pharmacies Image Figure 19. Hospital Pharmacies Image Figure 20. Global Rifapentine Sales Volume by Application (2021 VS 2025 VS 2032) & (kg) Figure 21. Global Rifapentine Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Rifapentine Sales Volume Share by Application (2021-2032) Figure 23. Global Rifapentine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Rifapentine Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Rifapentine Sales Value Share by Application (2021-2032) Figure 26. Global Rifapentine Sales by Region: 2021 VS 2025 VS 2032 (kg) Figure 27. Global Rifapentine Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Rifapentine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Rifapentine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Rifapentine Sales Value (2021-2032) & (US$ Million) Figure 31. North America Rifapentine Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Rifapentine Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Rifapentine Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Rifapentine Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Rifapentine Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Rifapentine Sales Value (2021-2032) & (US$ Million) Figure 37. South America Rifapentine Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Rifapentine Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Rifapentine Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Rifapentine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Rifapentine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Rifapentine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Rifapentine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Rifapentine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Rifapentine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Rifapentine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Rifapentine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Rifapentine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Rifapentine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Rifapentine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Rifapentine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Rifapentine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Rifapentine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Rifapentine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Rifapentine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Rifapentine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Rifapentine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Rifapentine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Rifapentine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Rifapentine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Rifapentine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Rifapentine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Rifapentine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Rifapentine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Rifapentine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Rifapentine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Rifapentine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Rifapentine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Rifapentine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Rifapentine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Rifapentine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Rifapentine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Rifapentine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Rifapentine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Rifapentine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Rifapentine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Rifapentine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Rifapentine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Rifapentine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Rifapentine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Rifapentine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Rifapentine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Rifapentine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Rifapentine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Rifapentine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Rifapentine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Rifapentine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Rifapentine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Rifapentine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Rifapentine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Rifapentine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Rifapentine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Rifapentine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Rifapentine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Rifapentine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Rifapentine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Rifapentine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Rifapentine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Rifapentine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Rifapentine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Rifapentine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Rifapentine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Rifapentine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Rifapentine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Rifapentine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Rifapentine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Rifapentine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Rifapentine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Rifapentine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Rifapentine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Rifapentine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Rifapentine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Rifapentine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Rifapentine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Rifapentine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Rifapentine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Rifapentine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Rifapentine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Rifapentine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Rifapentine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Rifapentine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Rifapentine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Rifapentine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Rifapentine Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Rifapentine Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • 20 Capsules/Box
  • 24 Capsules/Box
Applications
  • Retail Pharmacies
  • Online Pharmacies
  • Hospital Pharmacies
Companies covered
  • Changzheng Pharma
  • Sine Pharma
  • Sanofi
  • MED-SHINE
  • Foutune Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Rifapentine Sales Value (2021-2032)
  4. 1.2.2 Global Rifapentine Sales Volume (2021-2032)
  5. 1.2.3 Global Rifapentine Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Rifapentine Market Dynamics
  1. 2.1 Rifapentine Industry Trends
  2. 2.2 Rifapentine Industry Drivers
  3. 2.3 Rifapentine Industry Opportunities and Challenges
  4. 2.4 Rifapentine Industry Restraints
3 Rifapentine Market by Company
  1. 3.1 Global Rifapentine Company Revenue Ranking in 2025
  2. 3.2 Global Rifapentine Revenue by Company (2021-2026)
  3. 3.3 Global Rifapentine Sales Volume by Company (2021-2026)
  4. 3.4 Global Rifapentine Average Price by Company (2021-2026)
  5. 3.5 Global Rifapentine Company Ranking (2024-2026)
  6. 3.6 Global Rifapentine Company Manufacturing Base and Headquarters
  7. 3.7 Global Rifapentine Company Product Type and Application
  8. 3.8 Global Rifapentine Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Rifapentine Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Rifapentine Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Rifapentine Market by Type
  1. 4.1 Rifapentine Type Introduction
  2. 4.1.1 20 Capsules/Box
  3. 4.1.2 24 Capsules/Box
  4. 4.2 Global Rifapentine Sales Volume by Type
  5. 4.2.1 Global Rifapentine Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Rifapentine Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Rifapentine Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Rifapentine Sales Value by Type
  9. 4.3.1 Global Rifapentine Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Rifapentine Sales Value by Type (2021-2032)
  11. 4.3.3 Global Rifapentine Sales Value Share by Type (2021-2032)
5 Rifapentine Market by Application
  1. 5.1 Rifapentine Application Introduction
  2. 5.1.1 Retail Pharmacies
  3. 5.1.2 Online Pharmacies
  4. 5.1.3 Hospital Pharmacies
  5. 5.2 Global Rifapentine Sales Volume by Application
  6. 5.2.1 Global Rifapentine Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Rifapentine Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Rifapentine Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Rifapentine Sales Value by Application
  10. 5.3.1 Global Rifapentine Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Rifapentine Sales Value by Application (2021-2032)
  12. 5.3.3 Global Rifapentine Sales Value Share by Application (2021-2032)
6 Rifapentine Regional Sales and Value Analysis
  1. 6.1 Global Rifapentine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Rifapentine Sales by Region (2021-2032)
  3. 6.2.1 Global Rifapentine Sales by Region: 2021-2026
  4. 6.2.2 Global Rifapentine Sales by Region (2027-2032)
  5. 6.3 Global Rifapentine Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Rifapentine Sales Value by Region (2021-2032)
  7. 6.4.1 Global Rifapentine Sales Value by Region: 2021-2026
  8. 6.4.2 Global Rifapentine Sales Value by Region (2027-2032)
  9. 6.5 Global Rifapentine Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Rifapentine Sales Value (2021-2032)
  12. 6.6.2 North America Rifapentine Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Rifapentine Sales Value (2021-2032)
  15. 6.7.2 Europe Rifapentine Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Rifapentine Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Rifapentine Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Rifapentine Sales Value (2021-2032)
  21. 6.9.2 South America Rifapentine Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Rifapentine Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Rifapentine Sales Value Share by Country, 2025 VS 2032
7 Rifapentine Country-level Sales and Value Analysis
  1. 7.1 Global Rifapentine Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Rifapentine Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Rifapentine Sales by Country (2021-2032)
  4. 7.3.1 Global Rifapentine Sales by Country (2021-2026)
  5. 7.3.2 Global Rifapentine Sales by Country (2027-2032)
  6. 7.4 Global Rifapentine Sales Value by Country (2021-2032)
  7. 7.4.1 Global Rifapentine Sales Value by Country (2021-2026)
  8. 7.4.2 Global Rifapentine Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Rifapentine Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Rifapentine Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Rifapentine Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Rifapentine Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Rifapentine Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Rifapentine Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Rifapentine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Rifapentine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Rifapentine Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Rifapentine Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Rifapentine Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Rifapentine Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Rifapentine Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Rifapentine Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Rifapentine Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Rifapentine Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Rifapentine Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Rifapentine Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Rifapentine Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Rifapentine Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Rifapentine Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Rifapentine Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Rifapentine Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Rifapentine Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Rifapentine Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Rifapentine Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Rifapentine Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Rifapentine Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Rifapentine Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Rifapentine Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Rifapentine Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Rifapentine Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Rifapentine Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Rifapentine Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Rifapentine Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Rifapentine Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Rifapentine Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Rifapentine Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Rifapentine Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Rifapentine Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Rifapentine Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Rifapentine Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Rifapentine Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Rifapentine Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Rifapentine Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Rifapentine Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Rifapentine Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Rifapentine Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Rifapentine Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Rifapentine Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Rifapentine Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Rifapentine Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Rifapentine Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Rifapentine Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Rifapentine Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Rifapentine Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Rifapentine Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Rifapentine Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Rifapentine Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Rifapentine Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Rifapentine Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Rifapentine Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Rifapentine Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Rifapentine Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Rifapentine Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Rifapentine Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Rifapentine Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Rifapentine Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Rifapentine Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Rifapentine Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Rifapentine Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Rifapentine Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Rifapentine Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Rifapentine Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Rifapentine Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Rifapentine Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Rifapentine Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Rifapentine Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Rifapentine Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Rifapentine Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Rifapentine Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Rifapentine Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Rifapentine Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Rifapentine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Changzheng Pharma
  2. 8.1.1 Changzheng Pharma Company Information
  3. 8.1.2 Changzheng Pharma Business Overview
  4. 8.1.3 Changzheng Pharma Rifapentine Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Changzheng Pharma Rifapentine Product Portfolio
  6. 8.1.5 Changzheng Pharma Recent Developments
  7. 8.2 Sine Pharma
  8. 8.2.1 Sine Pharma Company Information
  9. 8.2.2 Sine Pharma Business Overview
  10. 8.2.3 Sine Pharma Rifapentine Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Sine Pharma Rifapentine Product Portfolio
  12. 8.2.5 Sine Pharma Recent Developments
  13. 8.3 Sanofi
  14. 8.3.1 Sanofi Company Information
  15. 8.3.2 Sanofi Business Overview
  16. 8.3.3 Sanofi Rifapentine Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Sanofi Rifapentine Product Portfolio
  18. 8.3.5 Sanofi Recent Developments
  19. 8.4 MED-SHINE
  20. 8.4.1 MED-SHINE Company Information
  21. 8.4.2 MED-SHINE Business Overview
  22. 8.4.3 MED-SHINE Rifapentine Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 MED-SHINE Rifapentine Product Portfolio
  24. 8.4.5 MED-SHINE Recent Developments
  25. 8.5 Foutune Pharma
  26. 8.5.1 Foutune Pharma Company Information
  27. 8.5.2 Foutune Pharma Business Overview
  28. 8.5.3 Foutune Pharma Rifapentine Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Foutune Pharma Rifapentine Product Portfolio
  30. 8.5.5 Foutune Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Rifapentine Value Chain Analysis
  2. 9.1.1 Rifapentine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Rifapentine Sales Mode & Process
  6. 9.2 Rifapentine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Rifapentine Distributors
  9. 9.2.3 Rifapentine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst